Human immunodeficiency virus type 1: resistance to nucleoside analogues and replicative capacity in primary human macrophages.
about
Extensive HIV-1 intra-host recombination is common in tissues with abnormal histopathologyImpact of the HIV-1 env genetic context outside HR1-HR2 on resistance to the fusion inhibitor enfuvirtide and viral infectivity in clinical isolatesHIV-1 polymerase inhibition by nucleoside analogs: cellular- and kinetic parameters of efficacy, susceptibility and resistance selectionLeishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection.Antiretroviral therapy in macrophages: implication for HIV eradication.Ribonucleoside triphosphates as substrate of human immunodeficiency virus type 1 reverse transcriptase in human macrophagesHuman immunodeficiency virus type 1 protease inhibitor drug-resistant mutants give discordant results when compared in single-cycle and multiple-cycle fitness assays.Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance.Mutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M viruses.The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell TransmissionInefficient vaginal transmission of tenofovir-resistant HIV-1Reduced dNTP binding affinity of 3TC-resistant M184I HIV-1 reverse transcriptase variants responsible for viral infection failure in macrophageClinical significance of human immunodeficiency virus type 1 replication fitness.Compensatory role of human immunodeficiency virus central polypurine tract sequence in kinetically disrupted reverse transcription.Screening of Potential HIV-1 Inhibitors/Replication Blockers Using Secure Lentiviral in Vitro System.Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection.
P2860
Q28475143-5B84B333-344B-4656-8923-9F816FDB3788Q28478943-B7A21344-7A97-43F2-9A8E-0106AB105B99Q28478993-87FC9737-4A38-4CB8-9EEF-7D83AAD02CD4Q34229670-663EF4EB-E0D4-43E1-9480-B0EEC408E93FQ34298792-64288CF9-DDE5-4B5B-8A2C-3151F32B4884Q34386057-F3DF08F5-4A9F-40E8-86B9-1C4C01FC74DEQ34489422-9ADD3784-6545-4D77-A9F6-CE56B5BAA2E0Q34615228-AC041596-7682-45DE-B7FF-81821D92F688Q34992731-90FC95C8-A82B-4E86-94F9-7ACE6D62D607Q36123960-B338C100-6DAC-4480-ACFD-6ECDD5E50B45Q36559597-615F98F1-3541-44F1-A2C6-48DB6E8C447CQ36727259-4159EF07-AE77-4615-9154-E0214DC9C2B9Q36969857-93A056E9-5248-4B97-868C-F2E9E65A9A0EQ41337841-CA21E7F0-4CA2-441B-9841-69191DE0BE4FQ41961457-7EA50B5F-24D3-4ADA-81C7-5123027FECDDQ52374199-481FBF07-5E9F-4515-AAB9-4BFBF3F42392
P2860
Human immunodeficiency virus type 1: resistance to nucleoside analogues and replicative capacity in primary human macrophages.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Human immunodeficiency virus t ...... in primary human macrophages.
@en
type
label
Human immunodeficiency virus t ...... in primary human macrophages.
@en
prefLabel
Human immunodeficiency virus t ...... in primary human macrophages.
@en
P2093
P2860
P356
P1433
P1476
Human immunodeficiency virus t ...... y in primary human macrophages
@en
P2093
Henri Benech
Sébastien Wurtzer
Séverine Compain
P2860
P304
P356
10.1128/JVI.01620-06
P407
P577
2007-02-07T00:00:00Z